Detalhe da pesquisa
1.
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
N Engl J Med
; 388(7): 621-634, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791162
2.
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
N Engl J Med
; 386(1): 35-46, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34752019
3.
Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial.
Clin Infect Dis
; 77(2): 312-320, 2023 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37125490
4.
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years.
Clin Infect Dis
; 75(3): 390-398, 2022 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940806
5.
The incidence of stroke among selected patients undergoing elective posterior lumbar fusion: a retrospective cohort study.
BMC Musculoskelet Disord
; 21(1): 612, 2020 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32928165
6.
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination.
Infect Dis Ther
; 13(4): 699-714, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489117
7.
Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds.
J Pediatric Infect Dis Soc
; 12(4): 234-238, 2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929216
8.
Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease.
Hum Vaccin Immunother
; 18(6): 2126253, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36368038
9.
Overstating social networks' ability to diagnose new cases of HIV.
Am J Public Health
; 100 Suppl 1: S5-6; author reply S6, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20147665